
Reviva Pharmaceuticals Holdings, Inc.
NASDAQRVPH short-sale utilization hits 97.03%, near the 52-week high of 100%, signaling tight share availability for borrowers.
Snapshot as of 6 May 2026
No long-form analysis yet for RVPH. Pulse alerts and the live data picture are available on ORTEX.
Open RVPH on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RVPH — free to start on ORTEX.
Sign up for free →Open RVPH on ORTEX